Medical/Pharmaceuticals

CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting

SUZHOU, China, Aug. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's CS1001-201 trial has been submitted to the upcoming 2019 American Society of Hematology (ASH) Annual Meeting. This will mark the first release of CS1001-201...

2019-08-20 10:18 269

China SXT Pharmaceuticals, Inc. Announces Filing of Annual Report on Form 20-F for Year Ended March 31, 2019

TAIZHOU, China, Aug. 19, 2019 /PR Newswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), today annou...

2019-08-19 20:00 859

Merck Granted Seven Additional CRISPR Patents, Bringing Total to 20 Worldwide

DARMSTADT, Germany, Aug. 19, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing seven additional Merck patent application claims covering CRISPR g...

2019-08-19 20:00 364

WuXi AppTec Reports First Half 2019 Interim Results

* Revenue Accelerated 33.7% Year-Over-Year to RMB 5,894 Million * Gross Profit Up 30.0% Year-Over-Year to RMB 2,284 million[1] * Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year toRMB 1,179 Million * Small Molecule CDMO/CMO Pipeline has Grown to 800...

2019-08-19 19:20 365

Abstract on CStone's CS1001-101 trial accepted for poster presentation at ESMO 2019 Annual Congress

SUZHOU, China, Aug. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's ongoing CS1001-101 Phase Ib clinical study has been accepted for poster presentation at the upcoming European Society for Medical Oncology (ESMO) 2019 Annua...

2019-08-19 13:50 1060

CSPC Pharmaceutical Announces 2019 Interim Results

Profit Attributable To Shareholders Increased 24.8% to RMB1,878 Million Innovative Drug Business Continued to Deliver Strong Growth R&D Investment Increased Significantly HONG KONG, Aug. 19, 2019 /PRNewswire/ -- CSPC Pharmaceutical Group Limited  (HKEx: 01093) ("CSPC Pharmaceutical" or the "Group")...

2019-08-19 12:20 485

IDTechEx Forecasts $6.1 Billion Market for 3D Printed Medical Devices

BOSTON, Aug. 19, 2019 /PRNewswire/ -- IDTechEx, a market intelligence and events company focused on emerging technologies, reports that the market for 3D printed medical devices and pharmaceuticals will be worth$6.1 billion by the year 2029. IDTechEx finds this to be a rapidly growing market with...

2019-08-19 09:08 496

Global market of dietary supplement is welcoming a rising star GLYMATE

BREA, California, Aug. 16, 2019 /PRNewswire/ -- Glymate™, a newly founded nutraceutical company inSouthern California. Its proprietary sugar balance dietary supplement was officially announced inthe United States in June 2019, marking the official launch of the global marketing of this product, w...

2019-08-16 21:00 1033

Xinhua Silk Road: Tasly remains China's 2019 National Tech Innovation Demonstration Enterprise

BEIJING, Aug. 16, 2019 /PRNewswire/ -- Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country's review of National Technology Innovation Demonstration Enterprise in 2019, thanks to its continuous innovations made in the recent years. Tasly ...

2019-08-16 10:56 1063

Venus Concept Announces Financial Results for the Second Quarter and First Six Months of 2019 and FDA 510(k) Clearance of Venus Bliss™

TORONTO, Aug. 16, 2019 /PRNewswire/ -- Venus Concept Ltd. ("Venus Concept"), a privately-held global medical aesthetic technology leader, provided unaudited financial results for the second quarter and first six months of 2019. Combined Company 2019 Revenue Outlook On March 15, 2019, Restoration...

2019-08-16 05:53 4275

Earlier Is Better ... New, Patented At-Home Blood Pregnancy Test, Available Exclusively From TAEUS, Offers Human Pregnancy Confirmation Within Days, Rather Than Weeks

COLORADO SPRINGS, Colorado, Aug. 15, 2019 /PRNewswire/ -- This US-patented invention, which allows women to confirm pregnancy at home, within days of conception, yielding a fundamental breakthrough in human pregnancy testing, is available for sale and/or license, exclusively through TAEUS Corpora...

2019-08-15 21:05 1141

United Imaging Announces First U.S. Clinical Installation and Patient Scans of the uEXPLORER Total-Body PET/CT System

HOUSTON, Aug. 15, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, today announced that its uEXPLORER total-body PET/CT system is now in use. United Imaging developed uEXPLORER in partnership with the EXPLORER Consortium led bySimon Che...

2019-08-15 20:00 866

China Pharma Holdings, Inc. Reports Second Quarter 2019 Financial Results

HAIKOU, China, Aug. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter...

2019-08-15 18:30 4561

111, Inc. Announces Second Quarter 2019 Unaudited Financial Results and US$10 Million Share Repurchase Program

SHANGHAI, Aug. 15, 2019 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the second quarter endedJune 30, 2019 and US$10 million share repurchase program. Seco...

2019-08-15 16:53 4461

CStone Pharmaceuticals Reports First Half 2019 Financial Results

SHANGHAI, Aug. 15, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and molecularly-targeted drugs for the treatment of cancer, today released its recent business ...

2019-08-15 15:31 4384

China Jo-Jo Drugstores Reports First Quarter 2020 Financial Results

HANGZHOU, China, Aug. 14, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider inChina, today announced i...

2019-08-14 21:00 4816

Combined Surgical Suction/Irrigation Technology Available Immediately

COLORADO SPRINGS, Colo., Aug. 13, 2019 /PRNewswire/ -- Globally patented integrated surgical closed-loop suction/irrigation technology is immediately available for purchase and/or license via TAEUS Corporation. Current suction/irrigation techniques (a.k.a. bulb syringes or "turkey basters," with...

2019-08-13 21:00 1101

CStone announces first patient dosed in China with BLU-667 for the global Phase I registrational study

SUZHOU, China, Aug. 13, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announces the dosing of the first patient inChina for the Phase I registrational study of BLU-667, which was discovered by the company's partner Blueprint Medicines. This clinical trial is a part of t...

2019-08-13 12:21 5727

VolitionRx Limited Announces Second Quarter 2019 Financial Results and Business Update

AUSTIN, Texas, Aug. 12, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter endedJune 30, 2019. Volition management will host a conference call tomorrow,August 13, at 8:30 a.m. U.S. Eastern Time ...

2019-08-13 04:05 6756

Concept Medical Inc. Granted 2nd 'Breakthrough Device Designation' From the FDA for Its MagicTouch PTA Sirolimus Coated Balloon, for the Treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK) Indication

Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Bel...

2019-08-13 02:48 1625
12345 ... 338